Since the objectives of this Regulation, namely to ensure the smooth functioning of the internal market as regards medical devices and to ensure high standards of quality and safety for in vitro diagnostic medical devices, thus ensuring a high level of protection of health and safety of patients, users and other persons, cannot be sufficiently achieved by the Member States but can rather, by reason of its scale and effects, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on European Union.
Ós rud é nach féidir leis na Ballstáit cuspóirí an Rialacháin seo, eadhon feidhmiú rianúil an mhargaidh inmheánaigh maidir le feistí leighis a áirithiú agus caighdeáin arda cáilíochta agus sábháilteachta feistí leighis diagnóiseacha in vitro a áirithiú, agus dá bharr sin go mbeidh ardleibhéal cosanta sláinte agus sábháilteachta othar ann, a ghnóthú go leordhóthanach agus, de bharr a fhairsinge agus a éifeachtaí, gur fearr is féidir iad a ghnóthú ar leibhéal an Aontais, féadfaidh an tAontas bearta a ghlacadh, i gcomhréir le prionsabal na coimhdeachta a leagtar amach in Airteagal 5 den Chonradh ar an Aontas Eorpach.